The Delhi High Court has granted pharmaceutical company Merck an injunction that prevents Glenmark Pharmaceuticals from making and selling its diabetes drugs Zita (sitagliptin) and Zitamet (sitagliptin/metformin).
Start a subscription today to access the LSIPR website.
To access the full archive, digital magazines and special reports you will need to take out a paid subscription.
If you have already subscribed please login.
If you have any technical issues please email tech support.
For access to the complete website, archive, and to receive print publications, choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial with full access, select ‘TWO WEEK FREE TRIAL’.
Merck Sharp & Dohme, Glenmark Pharmaceuticals, Zita, Januvia, Delhi High Court